Navigation Links
QIO to Be Upgraded

Medicare plans to improve quality and investigate complaints. The Institute of Medicine, said that Quality Improvement// Organizations (QIO) which is responsible for attending to patient complaints has to be removed and this job has to be given to various other organizations. This is because QIOs have not effectively worked and have issued fewer provider sanctions in recent years. This could be because QIOs may not want to have conflicts with its providers with which it works.

Medicare pays 53 QIOs about $300 million a year to measure quality, work with hospitals and physicians to improve care, and to investigate patient complaints. A 283-page report was prepared which recommended the following alterations in the system. It called for sharply increased oversight and more competition, less secrecy in the QIO operations and major revision of the governance of the physician-dominated groups, such as putting more consumers on their boards and making public the compensation paid to directors.

The panel called on Medicare officials to conduct more rigorous and independent studies of the QIOs' work and make use of those results to guide future decisions about the program. A Washington Post investigation in July found that QIOs place a low priority on patient complaints, investigating just 3,100 complaints from Medicare beneficiaries in 2004. it was seen that lavish salaries and perks were being paid to some QIO executives and board members. Many of the QIO boards are dominated by physicians and have only a single consumer. They lack finance or audit committees, and a strategic planning committee.

Stephen M. Shortell, dean of the School of Public Health at the University of California at Berkeley and chairman of the panel said that they were frozen for some time while they were being upgraded. More nurses, pharmacists and consumers are included.


'"/>




Page: 1

Related medicine news :

1. Kottayam Medical College To be Upgraded
2. Rohini Forensic Lab to Be Upgraded
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: